참고문헌
- Armson, B. A (2005). Maternal/fetal medicine committee, society of obstetricians and gynaecologists of Canada. Umbilical cord blood banking: implications for perinatal care providers. J. Obstet Gynaecol. Can. 27, 263-290
- Aslam, I. , Fishel, S., Moore, H., Dowell, K. and Thornton, S. (2000). Fertility preservation of boys undergoing anti-cancer therapy: a review of the existing situation and prospects for the future. Hum. Reprod. 15, 2154-2159 https://doi.org/10.1093/humrep/15.10.2154
- Bahadur, G. Ethics of testicular stem cell medicine. (2004). Hum Reprod., 19, 2702-2710 https://doi.org/10.1093/humrep/deh538
- Caplan, A. I. and Bruder, S. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mo.l Mol. 7, 259-264 https://doi.org/10.1016/S1471-4914(01)02016-0
- Caulfield, T., Knowles, L. and Meslin, E. M. (2004). Law and policy in the era of reproductive genetics. J. Med. Ethics 30, 414-417 https://doi.org/10.1136/jme.2002.001370
- Cogle, C. R., Guthrie, S. M., Sanders, R. C., Allen, W. L., Scott, E. W., and Petersen, B. E. (2003). An overview of stem cell research and regulatory issues. Mayo Clin. Proc. 78, 993-1003 https://doi.org/10.4065/78.8.993
- Deisseroth, A. B., Holmes, F, Hortobagyi, G. and Champlin, R. (1996). Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial. Hum. Gene Ther. 7, 401-16 https://doi.org/10.1089/hum.1996.7.3-401
- Hintzen, R. Q. (2002). Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges. Mult. Scler. 8, 155-160 https://doi.org/10.1191/1352458502ms789oa
- Kline, R. M., and Bertolone, S. J. (1998). Umbilical cord blood transplantation: providing a donor for everyone needing a bone marrow transplant? South. Med. J. 91, 821-828 https://doi.org/10.1097/00007611-199809000-00004
- Parens, E. and Knowles, L. P. (2003). Reprogenetics and public policy. Reflections and recommendation. Hastings Cent. Rep. 33, 1-24
- Prosper, F., Herreros, J. and Barba, J. (2004). Future perspectives in the treatment of heart failure: from cell transplantation to cardiac regeneration. Rev. Esp. Cardiol. 57, 981-988
- Romano, G. (2004). Stem cell transplantation therapy: controversy over ethical issues and clinical relevance. Drug News Perspect. 17,637-645 https://doi.org/10.1358/dnp.2004.17.10.873915
- Schatten, G. P. (2002). Safeguarding ART. Nat. Cell Biol. 4 Suppl, 19-22 https://doi.org/10.1038/ncb-nm-fertilityS19
- Schwartz, R. S. and Curfman, G. D. (2002). Can the heart repair itself? N. Engl. J. Med. 346, 2-4 https://doi.org/10.1056/NEJM200201033460102
- Teshima, A. and Harada, M. (1997). Mobilization of peripheral blood progenitor cells for allogeneic transplantation. Cytokines Cell Mol. Ther. 3, 101-114
- Testa, G. and Harris, J. (2005). Ethics and synthetic gametes. Bioethics 19, 146-166 https://doi.org/10.1111/j.1467-8519.2005.00431.x
- Yim, R. (2005). Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside. Transfusion 45, 144S-158 https://doi.org/10.1111/j.1537-2995.2005.00616.x